Solution: Federal And State Policy

Case Study: Navigating the Inflation Reduction Act

Insights,

| Anna Prokop, MA - Manager

ADVI Analysis: MedPAC January 2024 Meeting

Insights,

| Allison Schneider, MHA - Director

ADVI Instant: FDA Authorizes Florida’s Drug Importation Program

Insights,

| Melyssa Nocar - Head of Marketing and Communications

What’s Ahead for 2024?
ADVI Angle Vertical

Insights,

| Melyssa Nocar - Head of Marketing and Communications

What is Your Healthcare New Year’s Resolution?

Insights,

| Allison Schneider, MHA - Director

ADVI Analysis: MACPAC December 2023 Meeting

Insights,

| Heena Doshi, MPH - Manager

Highlights of Medicare Drug Price Negotiation Program Listening Sessions

Insights,

| Allison Schneider, MHA - Director

ADVI Instant: Revised Part B and D Inflation Rebate Guidance and Drug Pricing Updates
In The News Marc Samuels Shares Insight on Important 2024 Regulatory Decisions with Pharma’s Almanac